Instruction for use: ActastavI want this, give me price
Active substance Mesalazine
ATX Code A07EC02 Mesalazine
NSAIDs - Salicylic acid derivatives
Nosological classification (ICD-10)
K50 Crohn's disease [regional enteritis]
Crohn's disease, Crohn's disease with fistula, Granuloma of the intestine, Granulomatous enteritis, Crohn's disease, Regional ileitis, Terminal Ileitis, Enteritis regional
K51 Ulcerative colitis
Colitis acute ulcerative, Colitis ulcerative, Ulcerative-necrotic colitis, Colitis ulcerative-hemorrhagic nonspecific, Colitis ulcerative and trophic, Colitis ulcerative idiopathic, Colitis ulcerative nonspecific, Nonspecific ulcerative colitis, Proctocolitis ulcers, Hemorrhagic purulent rectoxitis, Rectoccolitis ulcerative-hemorrhagic
K52 Other noninfectious gastroenteritis and colitis
senile Bowel Syndrome, sigmoid, Gastroenteritis noninfectious, gastroenterocolitis, Colitis, Colitis non-dysenteric, Colitis noninfectious, Colitis is a chronic, Colitis is a chronic non-infectious, Local enteritis, sigmoid noninfectious, Chronic inflammatory bowel disease, Chronic inflammatory disease of the small intestine, Chronic enterocolitis, Chronic atrophic gastroenteritis, Chronic gastroenteritis, Chronic colitis, Chronic enterocolitis, Enteritis, non-infectious enteritis, Enterocolitis chronic noncommunicable, colon disease
K62 Other diseases of anus and rectum
Composition and form of release
1 tablet contains mesalazine 250 and 500 mg; in a package of 50 or 100 pcs .;
1 rectal suppository - 250 mg; in a package of 5 or 10 pcs.
Pharmacological action - anti-inflammatory.
After taking the majority of the dose reaches the ileum and large intestine (absorption is negligible), where the active substance is released (the dragee is covered with a special coating that prevents absorption in the stomach and proximal part of the small intestine).
Nonspecific ulcerative colitis; Crohn's disease (prevention and treatment of exacerbations), colitis chronic; proctitis.
Hypersensitivity (including to derivatives of salicylic acid), severe violations of liver function, hemorrhagic diathesis.
pregnancy and lactation
Headache, weakness, bronchospasm, pseudo erythritis, methemoglobinemia, allergic reactions.
Increases the toxicity of methotrexate, sulfonamides, furosemide, rifampicin, hypoglycemic effect of sulfonylurea derivatives and ulcerogenic effects of glucocorticoids.
Dosing and Administration
During exacerbations, inside - 0.5-1 g 3-4 times a day for 8-12 weeks; or rectally - 2 suppositories 3-4 times a day (ie, 1.5-2 g / day), in especially severe cases, the daily dose can be doubled. For the prevention of exacerbations - 0.25-0.5 g 3-4 times a day or 1 candle 3-4 times a day.
With prolonged therapy, regular blood and urine tests should be performed regularly.
In a dry, cool place protected from light.
Keep out of the reach of children.
Do not use after the expiry date printed on the package.